Hikma Pharmaceuticals US Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Hikma Pharmaceuticals US and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 2350 Hikma Pharmaceuticals US employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Hikma Pharmaceuticals US has purchased the following applications: SAP IBP for Advanced Planning and Scheduling in 2015, Microsoft Azure Cloud Services for Application Hosting and Computing Services in 2024, New Relic APM for Application Performance Management in 2012 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Hikma Pharmaceuticals US is running and its propensity to invest more and deepen its relationship with SAP , Microsoft , Amazon Web Services (AWS) or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Hikma Pharmaceuticals US revenues, which have grown to $1.94 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Hikma Pharmaceuticals US intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.

x